Skip to main content
. Author manuscript; available in PMC: 2015 May 1.
Published in final edited form as: Atherosclerosis. 2014 Mar 15;234(1):237–243. doi: 10.1016/j.atherosclerosis.2014.03.004

Figure 1. CR2-Crry protects against atherosclerosis in mCd59ab+/+/Apoe−/− mice.

Figure 1

A, Atherosclerosis analysis of en face aorta with oil red O staining in the HFD-fed mCd59ab+/+/Apoe−/− mice treated with CR2-Crry (n=7 males) or vehicle (n=6 males) for four months. Lesion area (%) is (oil red O staining area/aortic area) × 100. Scale bar: 2mm. B, H&E staining of aortic root in mCd59ab+/+/Apoe−/− mice shows that CR2-Crry treated mice have a smaller plaque than vehicle group. Lesion area (%) is (Plaque area/ventricle area) ×100. Scale bar: 100μm. *P<0.05;**P<0.005.